alexa Nano Medical Products: Challenges, Considerations And Strategies
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology
July 24-25, 2017 | Rome, Italy

Sabrina Gioria
JRC- European Commission, Directorate F – Health, Consumers and Reference Materials, Italy
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439-C1-049
Abstract
The rapid progress in the field of medical products involving nanotechnology makes the development of a coherent approach for their regulation a challenge. Robust and validated measurement methods are needed to allow informed regulatory decisions on their safety. Identifying critical physicochemical parameter that can have an impact on the products' quality and safety is extremely important. In particular, stability, size (-distribution), free vs. encapsulated drug content were considered as key parameters contributing to the biodistribution, pharmacokinetics (PK) and toxicity of nanoformulated drugs. Other parameters with an influence on the biological system are surface charge, surface chemistry, solubility and partition properties. Case studies of advanced methods for size-distribution, drug loading and drug-release in order to provide robust methods applicable to nanoproducts will be provided. In vitro toxicity testing is also an integral part for the identification of the hazardous potential of nano medical products in the early phase of their development. In vitro methods can provide initial insights of the toxic potential of e.g. a drug candidate at low costs and in a short timeframe. However, a caveat for the application of existing and highly standardized in vitro test methods for nanomedicine assessment is the interference of test reagents with the nanomaterial which can lead to false predictions of the assay. Here we address the pitfalls of existing toxicity testing when applied to nanomaterials and suggest alternatives. Progress in method development is essential to foster necessary standards that will support a harmonised regulation of nanomaterial-containing products. JRC scientific knowledge, technical competences and advanced instrumentation in the characterization of nanomaterials will be soon accessible to academia, public and industrial laboratories based within EU Member States and H2020 associated countries through the JRC Open Nano-Lab activities.
Biography

Sabrina Gioria is based in the Directorate F-Health, Consumers and Reference Materials, at the Joint Research Centre (JRC) in Italy. His research interest lies in investigating the in vitro toxicity of engineered nanomaterials (NMs) covering the development and optimization of test methods, the study of nanoparticles (NPs) uptake including the route of internalization, as well as investigating the mechanisms involved in NPs toxicity. She is part of the CORE expert team of the European Nanomedicine Characterization Laboratories (EU-NCL) and she is involved in the JRC-Open-Lab activities.

Email: sabrina.gioria@ec.europa.eu

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords